Okutucu, S.Katircioglu-Öztürk, D.Oto, E.Güvenir, H. A.Karaagaoglu, E.Oto, A.Meinertz, T.Goette, A.2018-04-122018-04-1220161099-5129http://hdl.handle.net/11693/37158Aims: The aims of this study include (i) pursuing data-mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial dataset containing atrial fibrillation (AF) burden scores of patients with many clinical parameters and (ii) revealing possible correlations between the estimated risk factors of AF and other clinical findings or measurements provided in the dataset. Methods: Ranking Instances by Maximizing the Area under a Receiver Operating Characteristics (ROC) Curve (RIMARC) is used to determine the predictive weights (Pw) of baseline variables on the primary endpoint. Chi-square automatic interaction detector algorithm is performed for comparing the results of RIMARC. The primary endpoint of the ANTIPAF-AFNET 2 trial was the percentage of days with documented episodes of paroxysmal AF or with suspected persistent AF. Results: By means of the RIMARC analysis algorithm, baseline SF-12 mental component score (Pw = 0.3597), age (Pw = 0.2865), blood urea nitrogen (BUN) (Pw = 0.2719), systolic blood pressure (Pw = 0.2240), and creatinine level (Pw = 0.1570) of the patients were found to be predictors of AF burden. Atrial fibrillation burden increases as baseline SF-12 mental component score gets lower; systolic blood pressure, BUN and creatinine levels become higher; and the patient gets older. The AF burden increased significantly at age >76. Conclusions: With the ANTIPAF-AFNET 2 dataset, the present data-mining analyses suggest that a baseline SF-12 mental component score, age, systolic blood pressure, BUN, and creatinine level of the patients are predictors of AF burden. Additional studies are necessary to understand the distinct kidney-specific pathophysiological pathways that contribute to AF burden. Published on behalf of the European Society of Cardiology.EnglishAtrial fibrillationBlood urea nitrogenCreatinineData miningMachine learningRIMARCSF-12Angiotensin II antagonistCreatinineNitrogenUreaAngiotensin receptor antagonistAntiarrhythmic agentAntihypertensive agentImidazole derivativeOlmesartanTetrazole derivativeAccuracyAgeAlgorithmArticleAtrial fibrillationControlled studyFemaleHumanMaleMeasurementMulticenter studyParoxysmal atrial fibrillationPriority journalProspective studyRandomized controlled trialRisk factorShort form 12Systolic blood pressureUrea nitrogen blood levelWeightAge distributionAgedAtrial fibrillationComorbidityData miningDouble blind procedureHypertensionIncidenceMiddle agedPrevalenceProceduresSex ratioTreatment outcomeVery elderlyAge DistributionAgedAged, 80 and overAngiotensin receptor antagonistsAnti-Arrhythmia agentsAntihypertensive agentsAtrial fibrillationComorbidityData miningDouble-Blind methodFemaleHumansHypertensionImidazolesIncidenceMaleMiddle agedPrevalenceRisk factorsSex distributionTetrazolesTreatment outcomeTurkeyArticle10.1093/europace/euw0841532-2092